Scoop: Blade Therapeutics CEO, CFO appear to depart amid ‘transition’ after nixed SPAC

The two top executives at Blade Therapeutics appear to no longer be with the biotech after the startup failed to merge with its SPAC partner earlier this year.

The biotech’s CEO and CFO no longer list the San Francisco-based drug developer as their employer on their LinkedIn pages, and other...

Click to view original post